Logo image of REPX

RILEY EXPLORATION PERMIAN IN (REPX) Stock Fundamental Analysis

NYSEARCA:REPX - NYSE Arca - US76665T1025 - Common Stock - Currency: USD

27.08  -0.12 (-0.44%)

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to REPX. REPX was compared to 211 industry peers in the Oil, Gas & Consumable Fuels industry. REPX scores excellent on profitability, but there are some minor concerns on its financial health. REPX may be a bit undervalued, certainly considering the very reasonable score on growth This makes REPX very considerable for value investing!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year REPX was profitable.
In the past year REPX had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: REPX reported negative net income in multiple years.
Of the past 5 years REPX 4 years had a positive operating cash flow.
REPX Yearly Net Income VS EBIT VS OCF VS FCFREPX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M

1.2 Ratios

The Return On Assets of REPX (9.93%) is better than 82.94% of its industry peers.
Looking at the Return On Equity, with a value of 18.55%, REPX is in the better half of the industry, outperforming 79.62% of the companies in the same industry.
The Return On Invested Capital of REPX (17.08%) is better than 92.42% of its industry peers.
REPX had an Average Return On Invested Capital over the past 3 years of 23.68%. This is in line with the industry average of 23.70%.
The last Return On Invested Capital (17.08%) for REPX is well below the 3 year average (23.68%), which needs to be investigated, but indicates that REPX had better years and this may not be a problem.
Industry RankSector Rank
ROA 9.93%
ROE 18.55%
ROIC 17.08%
ROA(3y)14.55%
ROA(5y)-8.31%
ROE(3y)26.42%
ROE(5y)-17.08%
ROIC(3y)23.68%
ROIC(5y)N/A
REPX Yearly ROA, ROE, ROICREPX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100

1.3 Margins

REPX has a Profit Margin of 23.92%. This is in the better half of the industry: REPX outperforms 75.83% of its industry peers.
REPX's Operating Margin of 47.39% is amongst the best of the industry. REPX outperforms 89.10% of its industry peers.
In the last couple of years the Operating Margin of REPX has grown nicely.
The Gross Margin of REPX (75.32%) is better than 86.26% of its industry peers.
REPX's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 47.39%
PM (TTM) 23.92%
GM 75.32%
OM growth 3Y4.43%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.84%
GM growth 5Y19.4%
REPX Yearly Profit, Operating, Gross MarginsREPX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

5

2. Health

2.1 Basic Checks

REPX has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for REPX has been increased compared to 1 year ago.
Compared to 5 years ago, REPX has more shares outstanding
Compared to 1 year ago, REPX has an improved debt to assets ratio.
REPX Yearly Shares OutstandingREPX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
REPX Yearly Total Debt VS Total AssetsREPX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

An Altman-Z score of 2.07 indicates that REPX is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of REPX (2.07) is better than 67.77% of its industry peers.
The Debt to FCF ratio of REPX is 1.97, which is an excellent value as it means it would take REPX, only 1.97 years of fcf income to pay off all of its debts.
REPX has a Debt to FCF ratio of 1.97. This is amongst the best in the industry. REPX outperforms 83.89% of its industry peers.
A Debt/Equity ratio of 0.43 indicates that REPX is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.43, REPX is in line with its industry, outperforming 52.61% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF 1.97
Altman-Z 2.07
ROIC/WACC1.81
WACC9.41%
REPX Yearly LT Debt VS Equity VS FCFREPX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

2.3 Liquidity

A Current Ratio of 0.44 indicates that REPX may have some problems paying its short term obligations.
REPX has a worse Current ratio (0.44) than 88.15% of its industry peers.
REPX has a Quick Ratio of 0.44. This is a bad value and indicates that REPX is not financially healthy enough and could expect problems in meeting its short term obligations.
REPX has a Quick ratio of 0.41. This is amonst the worse of the industry: REPX underperforms 87.68% of its industry peers.
Industry RankSector Rank
Current Ratio 0.44
Quick Ratio 0.41
REPX Yearly Current Assets VS Current LiabilitesREPX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 23.98% over the past year.
REPX shows a small growth in Revenue. In the last year, the Revenue has grown by 1.25%.
REPX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 142.30% yearly.
EPS 1Y (TTM)23.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%44.68%
Revenue 1Y (TTM)1.25%
Revenue growth 3Y39.52%
Revenue growth 5Y142.3%
Sales Q2Q%2.72%

3.2 Future

The Earnings Per Share is expected to grow by 5.88% on average over the next years.
REPX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.30% yearly.
EPS Next Y14.21%
EPS Next 2Y13.71%
EPS Next 3Y5.88%
EPS Next 5YN/A
Revenue Next Year0.93%
Revenue Next 2Y2.48%
Revenue Next 3Y2.3%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
REPX Yearly Revenue VS EstimatesREPX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M
REPX Yearly EPS VS EstimatesREPX Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2 4 6

9

4. Valuation

4.1 Price/Earnings Ratio

REPX is valuated cheaply with a Price/Earnings ratio of 4.44.
Based on the Price/Earnings ratio, REPX is valued cheaply inside the industry as 92.42% of the companies are valued more expensively.
REPX is valuated cheaply when we compare the Price/Earnings ratio to 27.45, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 3.69 indicates a rather cheap valuation of REPX.
Based on the Price/Forward Earnings ratio, REPX is valued cheaper than 96.68% of the companies in the same industry.
REPX is valuated cheaply when we compare the Price/Forward Earnings ratio to 21.90, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 4.44
Fwd PE 3.69
REPX Price Earnings VS Forward Price EarningsREPX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, REPX is valued cheaper than 87.68% of the companies in the same industry.
90.52% of the companies in the same industry are more expensive than REPX, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 4.71
EV/EBITDA 3.09
REPX Per share dataREPX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
REPX has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)0.31
PEG (5Y)N/A
EPS Next 2Y13.71%
EPS Next 3Y5.88%

6

5. Dividend

5.1 Amount

REPX has a Yearly Dividend Yield of 5.67%, which is a nice return.
Compared to an average industry Dividend Yield of 6.66, REPX pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.42, REPX pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.67%

5.2 History

REPX has been paying a dividend for over 5 years, so it has already some track record.
REPX has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years3
Div Non Decr Years3
REPX Yearly Dividends per shareREPX Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 0.5 1

5.3 Sustainability

REPX pays out 32.09% of its income as dividend. This is a sustainable payout ratio.
DP32.09%
EPS Next 2Y13.71%
EPS Next 3Y5.88%
REPX Yearly Income VS Free CF VS DividendREPX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M
REPX Dividend Payout.REPX Dividend Payout, showing the Payout Ratio.REPX Dividend Payout.PayoutRetained Earnings

RILEY EXPLORATION PERMIAN IN

NYSEARCA:REPX (7/3/2025, 8:05:35 PM)

27.08

-0.12 (-0.44%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)08-05 2025-08-05/amc
Inst Owners52.55%
Inst Owner Change-0.78%
Ins Owners5.12%
Ins Owner Change9.47%
Market Cap596.30M
Analysts82.22
Price Target57.97 (114.07%)
Short Float %2.52%
Short Ratio3.4
Dividend
Industry RankSector Rank
Dividend Yield 5.67%
Yearly Dividend1.47
Dividend Growth(5Y)N/A
DP32.09%
Div Incr Years3
Div Non Decr Years3
Ex-Date04-24 2025-04-24 (0.38)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-41.66%
Min EPS beat(2)-68.25%
Max EPS beat(2)-15.07%
EPS beat(4)1
Avg EPS beat(4)-7.46%
Min EPS beat(4)-68.25%
Max EPS beat(4)63.95%
EPS beat(8)2
Avg EPS beat(8)-17.4%
EPS beat(12)5
Avg EPS beat(12)-14.31%
EPS beat(16)5
Avg EPS beat(16)-31.46%
Revenue beat(2)0
Avg Revenue beat(2)-1.71%
Min Revenue beat(2)-1.72%
Max Revenue beat(2)-1.7%
Revenue beat(4)0
Avg Revenue beat(4)-2.3%
Min Revenue beat(4)-3.19%
Max Revenue beat(4)-1.7%
Revenue beat(8)4
Avg Revenue beat(8)1.49%
Revenue beat(12)8
Avg Revenue beat(12)41.49%
Revenue beat(16)12
Avg Revenue beat(16)38.85%
PT rev (1m)8%
PT rev (3m)8%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-13.68%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-8.65%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-4.55%
Valuation
Industry RankSector Rank
PE 4.44
Fwd PE 3.69
P/S 1.44
P/FCF 4.71
P/OCF 2.48
P/B 1.12
P/tB 1.12
EV/EBITDA 3.09
EPS(TTM)6.1
EY22.53%
EPS(NY)7.34
Fwd EY27.12%
FCF(TTM)5.75
FCFY21.22%
OCF(TTM)10.92
OCFY40.34%
SpS18.75
BVpS24.18
TBVpS24.18
PEG (NY)0.31
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 9.93%
ROE 18.55%
ROCE 22.41%
ROIC 17.08%
ROICexc 17.25%
ROICexgc 17.25%
OM 47.39%
PM (TTM) 23.92%
GM 75.32%
FCFM 30.64%
ROA(3y)14.55%
ROA(5y)-8.31%
ROE(3y)26.42%
ROE(5y)-17.08%
ROIC(3y)23.68%
ROIC(5y)N/A
ROICexc(3y)24.26%
ROICexc(5y)N/A
ROICexgc(3y)24.26%
ROICexgc(5y)N/A
ROCE(3y)31.08%
ROCE(5y)N/A
ROICexcg growth 3Y1.22%
ROICexcg growth 5YN/A
ROICexc growth 3Y1.22%
ROICexc growth 5YN/A
OM growth 3Y4.43%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.84%
GM growth 5Y19.4%
F-Score4
Asset Turnover0.41
Health
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF 1.97
Debt/EBITDA 0.84
Cap/Depr 149.51%
Cap/Sales 27.61%
Interest Coverage 6.72
Cash Conversion 88.45%
Profit Quality 128.09%
Current Ratio 0.44
Quick Ratio 0.41
Altman-Z 2.07
F-Score4
WACC9.41%
ROIC/WACC1.81
Cap/Depr(3y)429.72%
Cap/Depr(5y)307.72%
Cap/Sales(3y)65.26%
Cap/Sales(5y)47.88%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)23.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%44.68%
EPS Next Y14.21%
EPS Next 2Y13.71%
EPS Next 3Y5.88%
EPS Next 5YN/A
Revenue 1Y (TTM)1.25%
Revenue growth 3Y39.52%
Revenue growth 5Y142.3%
Sales Q2Q%2.72%
Revenue Next Year0.93%
Revenue Next 2Y2.48%
Revenue Next 3Y2.3%
Revenue Next 5YN/A
EBIT growth 1Y-2.22%
EBIT growth 3Y45.7%
EBIT growth 5YN/A
EBIT Next Year63.14%
EBIT Next 3Y19.44%
EBIT Next 5YN/A
FCF growth 1Y359.85%
FCF growth 3Y65.66%
FCF growth 5YN/A
OCF growth 1Y58.73%
OCF growth 3Y41.96%
OCF growth 5Y305.01%